Skip to content

TAP Block With Magnesium Sulfate Added to Local Anesthetic in Abdominal Hysterectomy

Efficacy and Safety of Magnesium Sulfate Added to Local Anesthetic in TAP Block for Postoperative Analgesia Following Total Abdominal Hysterectomy.

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02930707
Enrollment
60
Registered
2016-10-12
Start date
2016-01-31
Completion date
2016-11-30
Last updated
2016-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

magnesium sulfate, postoperative pain, TAP block, total abdominal hysterectomy

Brief summary

Major abdominal surgeries are associated with severe abdominal pain, which can affect respiratory and cardiac functions, if insufficiently managed. This increases the incidence of post-operative morbidity. The objective of this study was to detect the efficacy and safety of magnesium sulphate as an adjuvant to the analgesia offered by local anesthetic in ultrasound guided TAP block in patients undergoing total abdominal hysterectomy.

Interventions

DRUGMagnesium Sulfate

ultrasound guided TAP block with 20 mL of 0.25% bupivacaine plus 2 mL magnesium sulfate 10% (200 mg), on each side of the abdominal wall.

DRUGBupivacaine

ultrasound guided TAP block with 20 mL of 0.25% bupivacaine on each side of the abdominal wall.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* weight: 50- 85 kg. * ASA score: I-III * scheduled for total abdominal hysterectomy

Exclusion criteria

* history of relevant drug allergy. * coagulation disorders. * opioid dependence. * sepsis. * psychiatric illnesses that would interfere with perception and assessment of pain.

Design outcomes

Primary

MeasureTime frameDescription
total postoperative morphine consumptionpostoperative 24 hourstotal amount of rescue morphine consumption in the first 24 hours postoperatively

Secondary

MeasureTime frameDescription
postoperative painpostoperative 24 hourspostoperative pain measured by VAS score recorded in the first 24 hours postoperatively
first request of rescue analgesiapostoperative 24 hourstime to the first requirement of rescue analgesia during the first 24 hours postoperatively
side effectspostoperative 24 hoursoccurrence of side effects during the first 24 hours postoperatively

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026